About 200 reports

  • RECORDATI ACQUIRED ITALCHIMICI S.P.A.
  • VECTURA MERGED WITH SKYEPHARMA
  • Respiratory Disease
  • World
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Growing a diversified business Simplifying the operating model for increasing efficiency
  • YOY REVENUE COMPARISON OF TOP DRUGS FOR ALLERGIC RHINITIS 2012-2014 ($ BILLIONS)
  • Allergy Drug
  • Respiratory Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Global respiratory disease testing market by test
  • GLOBAL RESPIRATORY DISEASE TESTING MARKET 2014-2019 ($ BILLIONS)
  • Respiratory Disease
  • World
  • Alere Inc.
  • CareFusion Corporation
  • Nihon Kohden Corporation
  • Market drivers

The death rates are consistently higher in men than women for respiratory diseases.

  • Respiratory Disease
  • Boston Scientific Corporation
  • Broncus Medical Inc.
  • Medtronic, Inc.
  • Olympus Corporation
  • RISE IN HOSPITAL ADMISSION FOR RESPIRATORY DISEASES
  • GROWING INCIDENCE OF CHRONIC RESPIRATORY DISEASES
  • Respiratory Disease
  • World
  • Market Size
  • CareFusion Corporation
  • Teleflex Incorporated
  • NASAL CANNULA MARKET IN AMERICAS
  • NASAL CANNULA MARKET IN APAC

It can cause various diseases, such as respiratory diseases and cancers, which may require surgical treatment to avoid mortality.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Teleflex Incorporated
  • INHALERS MARKET IN GLOBAL ASTHMA DRUG-DELIVERY DEVICES MARKET 2015-2020 ($ MILLIONS)
  • GLOBAL ASTHMA THERAPEUTICS MARKET: KEY PARAMETERS DRIVING THE MARKET GROWTH 2015
  • Asthma
  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.

Discovers drugs to treat chronic respiratory diseases, including asthma and allergic rhinitis.

  • Respiratory Disease
  • Market Size
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • VENTURI MASKS MARKET IN APAC
  • Venturi masks market in APAC is expected to grow at a CAGR of 17.06% during the forecast period.

The rising older population is linked to the increasing patient pool with low mobility and need for long-term care for Alzheimer' s disease and other chronic respiratory diseases.

  • Respiratory Disease
  • Europe
  • United States
  • World
  • Forecast
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL SIZE BY STAGE OF
  • 4.4.3.3 Molecular Target
  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • BRAZIL OXYGEN THERAPY EQUIPMENT MARKET, BY APPLICATION
  • GLOBAL P.M 2.5 AIR POLLUTION, MEAN ANNUAL EXPOSURE, BY SELECT COUNTRIES, 2015
  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • OTHER PROMINENT VENDORS

It undertakes the discovery and development of drugs for the treatment of respiratory diseases.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • SHARE OF DISABILITY ADJUSTED LIFE YEARS FROM CHRONIC RESPIRATORY DISEASE,...
  • SHARE OF DEATHS FROM CHRONIC RESPIRATORY DISEASE, 2010
  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • RISE IN PREVALENCE OF RESPIRATORY DISEASES
  • INCREASING AWARENESS ABOUT RESPIRATORY DISEASES
  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • 3.3.1 DRIVERS AND OPPORTUNITIES
  • 3.3 FACTORS INFLUENCING MARKET
  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.

Key products Dymista OTHER PROMINENT VENDORS Company ADAMIS PHARMACEUTICALS Description Develops and distributes specialty pharmaceutical products in therapeutic areas including oncology, immunology, infectious diseases, allergy, and respiratory Develops drugs to treat and prevent

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Strengths
  • 5.1 DISEASE BACKGROUND

CHRONIC RESPIRATORY DISEASES.

  • Respiratory Disease
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.

Bovine Respiratory Disease Treatment Market Overview ##. ##.

  • Cattle
  • Chronic Disease
  • Respiratory Disease
  • World
  • Market Size
  • Strength
  • Vendor landscape

The company is a global biopharmaceutical company that manufactures, develops, distributes, and researches medicines for the treatment of cardiovascular and metabolic diseases; oncology diseases; respiratory diseases, inflammation and autoimmunity disorders and in

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Second quartile
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIAL SIZE BY STAGE OF
  • Respiratory Disease
  • World
  • Market Size
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • 9.1 REFERENCES
  • 5.3 FIRST-IN-CLASS PIPELINE PROGRAMS TARGETING NOVEL MOLECULAR TARGETS

Major Respiratory Diseases.

  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • ADULT POPULATION WITH SINUSITIS AND CHRONIC RHINITIS IN US 2014 (MILLION)

Respiratory diseases such as sinusitis and hay fever/ rhinitis are some of the diseases that affect a large population and are therefore a major concern.

  • Allergy Drug
  • Respiratory Disease
  • Forecast
  • Novartis AG
  • Sanofi S.A.
  • Market drivers
  • Introduction

They are used for the treatment of cystic fibrosis, asthma, COPD, and other respiratory diseases.

  • Respiratory Disease
  • Bespak plc
  • Consort Medical plc
  • Gerresheimer AG
  • Nypro Inc.
  • Asthma Therapeutics, Global, Clinical Trial Size per Individual Trial by Stage of
  • 6.6.1 TREATMENT USAGE PATTERNS

Pediatric Allergy and Respiratory Disease.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • UltraAir Pro NE-U17: A professional, ultrasonic nebulizer for the clinical treatment of lower...
  • Product categories
  • Respiratory Disease
  • World
  • Market Segment
  • Market Size
  • Omron Corporation
  • Rising incidence of chronic respiratory diseases
  • MARKET DRIVERS
  • Hospital
  • Respiratory Disease
  • United States
  • World
  • Forecast
  • 4.1.3 Rising Prevalence of Non Communicable Diseases
  • ASTRAZENECA REVENUE BY THERAPEUTIC SEGMENT (2013/2014)
  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG

Growing prevalence of respiratory diseases such as COPD, asthma is increasing the demand for respiratory disease testing/ diagnostic in North American countries.

  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • Forecast
  • Geographical segmentation
  • Market drivers

The overall treatment costs for respiratory diseases are increasing.

  • Respiratory Disease
  • World
  • Market Size
  • DeVilbiss Healthcare LLC
  • Omron Corporation
  • Asthma Therapeutics, Global, All Pipeline Products, Discovery, 2015
  • 8.1 Co-development Deals

European Respiratory Disease; ##(##): ##-## Salter M, et al. (2007).

  • Respiratory Disease
  • Asia
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc